Literature DB >> 1849671

Recurrence of Fabry's disease in a renal allograft eleven years after successful renal transplantation.

J F Mosnier1, C Degott, J Bedrossian, G Molas, F Degos, A Pruna, F Potet.   

Abstract

A case of Fabry's disease in a renal transplant recipient with a follow-up period of 11 years is reported. The patient suffered from renal, skin, peripheral nerve lesions, and asymptomatic cardiomegaly. Fabry's disease symptoms disappeared after transplantation. Improvement of renal function was rapidly observed, and it remained satisfactory during the whole posttransplantation period. The patient died of a severe, uncontrolled infection and of biliary peritonitis. Autopsy showed a polyvisceral accumulation of sphingolipids deposits. The engrafted kidney was histologically free of disease. Ultrastructurally, it revealed numerous sphingolipid inclusions in the endothelial cells of capillaries. The explanation of this complication could be attributed to: (1) high circulating levels of plasma substrates locally overwhelming the enzymatic capability of the graft endothelial cells; and (2) the endothelial cells originated from the recipient but not from the donor, an occurrence that has been described after transplantation. Rejection and the newly formed deposits in the endothelial cells may lead to the loss of the engrafted organ. As a consequence of the increasing possibility of organ transplantation, this complication should be detected by studying the blood vessels ultrastructurally in order to evaluate the condition of the transplant.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1849671     DOI: 10.1097/00007890-199104000-00004

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  6 in total

1.  Anderson-Fabry disease in Austria.

Authors:  Matthias Lorenz; Anna-Christina Hauser; Margot Püspök-Schwarz; Peter Kotanko; Ingrid Arias; Herbert Zodl; Reinhard Kramar; Eduard Paschke; Till Voigtländer; Gere Sunder-Plassmann
Journal:  Wien Klin Wochenschr       Date:  2003-04-30       Impact factor: 1.704

Review 2.  Renal pathological changes in Fabry disease.

Authors:  A Sessa; M Meroni; G Battini; A Maglio; P L Brambilla; M Bertella; M Nebuloni; F Pallotti; F Giordano; B Bertagnolio; A Tosoni
Journal:  J Inherit Metab Dis       Date:  2001       Impact factor: 4.982

Review 3.  Fabry's disease: a multidisciplinary disorder.

Authors:  F P Peters; A Sommer; A Vermeulen; E C Cheriex; T L Kho
Journal:  Postgrad Med J       Date:  1997-11       Impact factor: 2.401

4.  Elevated globotriaosylsphingosine is a hallmark of Fabry disease.

Authors:  Johannes M Aerts; Johanna E Groener; Sijmen Kuiper; Wilma E Donker-Koopman; Anneke Strijland; Roelof Ottenhoff; Cindy van Roomen; Mina Mirzaian; Frits A Wijburg; Gabor E Linthorst; Anouk C Vedder; Saskia M Rombach; Josanne Cox-Brinkman; Pentti Somerharju; Rolf G Boot; Carla E Hollak; Roscoe O Brady; Ben J Poorthuis
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-19       Impact factor: 11.205

5.  Outcomes of Kidney Transplantation in Fabry Disease: A Meta-Analysis.

Authors:  Maria L Gonzalez Suarez; Charat Thongprayoon; Panupong Hansrivijit; Juan Medaura; Pradeep Vaitla; Michael A Mao; Tarun Bathini; Boonphiphop Boonpheng; Swetha R Kanduri; Karthik Kovvuru; Arpita Basu; Wisit Cheungpasitporn
Journal:  Diseases       Date:  2020-12-23

Review 6.  Kidney Transplant in Fabry Disease: A Revision of the Literature.

Authors:  Irene Capelli; Valeria Aiello; Lorenzo Gasperoni; Giorgia Comai; Valeria Corradetti; Matteo Ravaioli; Elena Biagini; Claudio Graziano; Gaetano La Manna
Journal:  Medicina (Kaunas)       Date:  2020-06-10       Impact factor: 2.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.